Cargando…

Severe Acute Respiratory Syndrome Coronavirus 2–Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells

Studies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–infected patients and experimentally infected animals indicate a critical role for augmented expression of proinflammatory chemokines and cytokines in severe disease. Here, we demonstrate that SARS-CoV-2 infection of human monoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Jian, Wang, Yuhang, Li, Kun, Meyerholz, David K, Allamargot, Chantal, Perlman, Stanley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799009/ https://www.ncbi.nlm.nih.gov/pubmed/33277988 http://dx.doi.org/10.1093/infdis/jiaa753

Ejemplares similares

Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection
por: Channappanavar, Rudragouda, et al.
Publicado: (2015)

Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4
por: Li, Kun, et al.
Publicado: (2016)

Phenotype and Function of CD209(+) Bovine Blood Dendritic Cells, Monocyte-Derived-Dendritic Cells and Monocyte-Derived Macrophages
por: Park, Kun Taek, et al.
Publicado: (2016)

The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection
por: Fehr, Anthony R., et al.
Publicado: (2016)

Human Coronavirus EMC Is Not the Same as Severe Acute Respiratory Syndrome Coronavirus
por: Perlman, Stanley, et al.
Publicado: (2013)

Correction: Phenotype and Function of CD209(+) Bovine Blood Dendritic Cells, Monocyte-Derived-Dendritic Cells and Monocyte-Derived Macrophages
por: Park, Kun Taek, et al.
Publicado: (2017)

Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
por: Klingler, Jéromine, et al.
Publicado: (2020)

T-Cell Expression of Angiotensin-Converting Enzyme 2 and Binding of Severe Acute Respiratory Coronavirus 2
por: Welch, Jennifer L, et al.
Publicado: (2021)

Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms
por: Cunningham, Janet L, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody Deficiency
por: Pulvirenti, Federica, et al.
Publicado: (2021)

Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract
por: Lewnard, Joseph A, et al.
Publicado: (2021)

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Crawford, Katharine H D, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 Total and Subgenomic RNA Viral Load in Hospitalized Patients
por: Dimcheff, Derek E, et al.
Publicado: (2021)

High Infection Secondary Attack Rates of Severe Acute Respiratory Syndrome Coronavirus 2 in Dutch Households Revealed by Dense Sampling
por: Reukers, Daphne F M, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses
por: Lawrenz, Jan, et al.
Publicado: (2022)

Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology
por: Dee, Kieran, et al.
Publicado: (2021)

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
por: Channappanavar, Rudragouda, et al.
Publicado: (2016)

Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection
por: Pelleau, Stéphane, et al.
Publicado: (2021)

Relationship Between Anxiety, Depression, and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Proof of Concept
por: Vedhara, Kavita, et al.
Publicado: (2022)

Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice
por: Bao, Linlin, et al.
Publicado: (2020)

Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Magnus, Maria C, et al.
Publicado: (2022)

Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses
por: Petrie, Joshua G, et al.
Publicado: (2021)

Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March–May 2020
por: Kotwa, Jonathon D, et al.
Publicado: (2021)

Reprogramming monocyte-derived macrophages through caspase inhibition
por: Chaintreuil, Paul, et al.
Publicado: (2021)

Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus
por: Rockx, Barry, et al.
Publicado: (2010)

A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2
por: Weiss, Svenja, et al.
Publicado: (2020)

Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Memel, Zoe N, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali
por: Woodford, John, et al.
Publicado: (2021)

Racial, Ethnic, and Geographic Disparities in Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Test Positivity in North Carolina
por: Turner, Nicholas A, et al.
Publicado: (2020)

Respiratory Failure and Death in Vulnerable Premature Children With Lower Respiratory Tract Illness
por: Ofman, Gaston, et al.
Publicado: (2020)

Autocrine Interferon Priming in Macrophages but Not Dendritic Cells Results in Enhanced Cytokine and Chemokine Production after Coronavirus Infection
por: Zhou, Haixia, et al.
Publicado: (2010)

Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs Conundrums
por: Goldstein, Ellie J C, et al.
Publicado: (2020)

US Severe Acute Respiratory Syndrome Coronavirus 2 Epsilon Variant: Highly Transmissible but With an Adjusted Muted Host T-Cell Response
por: Plummer, Jasmine T, et al.
Publicado: (2022)

A Distinct Phylogenetic Cluster of Indian Severe Acute Respiratory Syndrome Coronavirus 2 Isolates
por: Banu, Sofia, et al.
Publicado: (2020)

Modeling transmission dynamics of severe acute respiratory syndrome coronavirus 2 in São Paulo, Brazil
por: da Cruz, Pedro Alexandre, et al.
Publicado: (2021)

Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness
por: Tiwari-Heckler, Shilpa, et al.
Publicado: (2021)

Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure
por: Andrejko, Kristin L, et al.
Publicado: (2021)

Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma
por: Nguyen, Dung, et al.
Publicado: (2021)

Introduction, Transmission Dynamics, and Fate of Early Severe Acute Respiratory Syndrome Coronavirus 2 Lineages in Santa Clara County, California
por: Villarino, Elsa, et al.
Publicado: (2021)

BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12–17 Years, by Dosing Interval and Duration
por: Ionescu, Iulia G, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ofl929pi9bho7s7ob4rusf2n8